반응식
[CH2:1]([O:3][C:4]([CH:6]1[CH2:11][CH2:10][CH:9]([NH2:12])[CH2:8][CH2:7]1)=[O:5])[CH3:2].[CH3:13][S:14]([CH2:17][CH2:18][O:19][C:20]1[CH:28]=[CH:27][CH:26]=[C:25]2[C:21]=1[CH:22]=[N:23][N:24]2[C:29]1[CH:34]=[CH:33][N:32]=[C:31](S(CCC)(=O)=O)[N:30]=1)(=[O:16])=[O:15]>>[CH2:1]([O:3][C:4]([CH:6]1[CH2:11][CH2:10][CH:9]([NH:12][C:31]2[N:30]=[C:29]([N:24]3[C:25]4[C:21](=[C:20]([O:19][CH2:18][CH2:17][S:14]([CH3:13])(=[O:15])=[O:16])[CH:28]=[CH:27][CH:26]=4)[CH:22]=[N:23]3)[CH:34]=[CH:33][N:32]=2)[CH2:8][CH2:7]1)=[O:5])[CH3:2]참가 물질
3
실험 절차
4-{4-[4-(2-Methanesulfonyl-ethoxy)-indazol-1-yl]-pyrimidin-2-ylamino}-cyclohexanecarboxylic acid ethyl ester was prepared by reaction of 4-amino-cyclohexanecarboxylic acid ethyl ester with 4-(2-methanesulfonyl-ethoxy)-1-[2-(propane-1-sulfonyl)-pyrimidin-4-yl]-1H-indazole following generally the procedure of Example 5.
출처 및 근거
- ORD 기록
- ord-b29759cd655348749faf06ccf7b1ef82
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08642601B2
연결된 노트
불러오는 중…